By Dominic Chopping
Novo Nordisk launched its hugely popular Wegovy injectable weight-loss drug in the U.K. Monday, despite continuing challenges the company has been facing in meeting surging demand for the treatment.
The Danish pharmaceutical giant on Friday overtook French luxury conglomerate LVMH Moet Hennessy Louis Vuitton as Europe’s…
Read the full article here
